港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

康方生物

87.300

+0.1000.11%

成交量：1,584.69万

成交额：14.01亿

市值：783.95亿

市盈率：-135.28

高：91.300

开：88.000

低：86.600

收：87.200

数据加载中...

总览公司新闻公告

康方生物：依沃西头对头帕博利珠单抗Ⅲ期临床研究结果全文发表

每日经济新闻

康方生物(09926.HK)卡度尼利治疗高复发风险肝细胞癌三期临床完成患者入组

阿斯达克财经

康方生物(09926)出现大手买入6.9万股，成交价$73.2，涉资505.08万

阿斯达克财经

康方生物03月04日主力净流入2016万元散户资金抛售

康方生物盘中异动股价大跌5.46%报67.500港元

国泰君安：国产创新药全球竞争力凸显经营拐点临近

《大行》中金列出中资股策略首选组合(表)

阿斯达克财经

【券商聚焦】中信建投予康方生物(09926)“买入”评级指其早研管线储备丰富具长期可持续发展能力

《大行》建银国际降康方生物(09926.HK)目标价至85元海外临床试验前景更明朗维持“跑赢大市”评级

阿斯达克财经

康方生物盘中异动快速上涨5.01%

【首个自研ADC澳洲临床入组康方生物IO 2+ADC战略再进一步】近日，康方生物宣布，公司自主研发的差异化靶向人表皮生长因子受体3（HER3）ADC新药AK138D1，治疗晚期恶性肿瘤的I期临床研究在澳洲完成首例受试者入组。AK138D1是康方生物首个进入临床阶段的ADC药物。ADC药物是康方生物在全球范围内重塑治疗格局，构建肿瘤治疗新标准，以创新疗法造福全球患者的重要力量，也是康方生物推进“IO 2.0+ADC”战略的重要抓手。目前康方生物自主研发的全球首创双抗新药卡度尼利（PD-1/CTLA-4双抗）和依沃西（PD-1/VEGF双抗）均已获批上市。康方生物是全球唯一拥有2个肿瘤免疫治疗双抗的制药公司，在IO+ADC联合战略中已经建立了在肿瘤免疫端的全球领先优势。AK138D1等差异化ADC药物的开发，为康方生物充分挖掘创新产品组合的临床价值，持续迭代肿瘤疗法开拓了更广阔的空间。

康方生物：HER3 ADC临床启动 IO2.0+ADC战略加速

港股概念追踪|百济神州成为国内“创新药一哥” 机构看好创新药2025年估值修复（附概念股）

【券商聚焦】交银国际维持康方生物(09926)买入评级指PD-1双抗+ADC联用潜力值得期待

康方生物(9926.HK)：合作伙伴SUMMIT与辉瑞探究联合疗法赋能AK112全球临床

中信建投证券

康方生物：SUMMIT与PFIZER携手探索AK112联用ADC

头对头单药击败K药后，依沃西牵手辉瑞ADC

港股异动 | 康方生物(09926)涨超5% 依沃西将与辉瑞多个ADCs药物开展联合疗法临床试验

康方生物盘中异动股价大涨5.03%

康方生物(09926.HK)依沃西与辉瑞(PFE.US)ADCs药物开展联合疗法临床试验

阿斯达克财经

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/09926/news?page=10"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09926","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09926\",,,,,undefined,":{"symbol":"09926","market":"HK","secType":"STK","nameCN":"康方生物","latestPrice":87.3,"timestamp":1745914087037,"preClose":87.2,"halted":0,"volume":15846889,"delay":0,"floatShares":898000000,"shares":898000000,"eps":-0.6453479659241673,"marketStatus":"未开盘","change":0.1,"latestTime":"04-29 16:08:07","open":88,"high":91.3,"low":86.6,"amount":1400648905,"amplitude":0.053899,"askPrice":87.35,"askSize":8000,"bidPrice":87.25,"bidSize":11000,"shortable":3,"etf":0,"ttmEps":-0.6453479659241673,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745976600000},"marketStatusCode":0,"adr":0,"listingDate":1587657600000,"exchange":"SEHK","adjPreClose":87.2,"openAndCloseTimeList":[[1745890200000,1745899200000],[1745902800000,1745913600000]],"volumeRatio":0.5450990310885895,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09926\",,,,,undefined,":{"symbol":"09926","floatShares":898000000,"roa":"-4.16%","roe":"-8.89%","lyrEps":-0.645348,"volumeRatio":0.5450990310885895,"shares":898000000,"dividePrice":0,"high":91.3,"amplitude":0.053899,"preClose":87.2,"low":86.6,"week52Low":26.45,"pbRate":"10.78","psRate":"34.58","week52High":105.5,"institutionHeld":0,"latestPrice":87.3,"committee":0.157895,"eps":-0.6453479659241673,"divideRate":0,"volume":15846889,"delay":0,"ttmEps":-0.6453479659241673,"open":88,"prevYearClose":60.7,"prevWeekClose":98.9,"prevMonthClose":76.2,"prevQuarterClose":76.2,"fiveDayClose":88.4,"twentyDayClose":70.95,"sixtyDayClose":59.8},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09926\",pageSize:20,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517122854","title":"康方生物：依沃西头对头帕博利珠单抗Ⅲ期临床研究结果全文发表","url":"https://stock-news.laohu8.com/highlight/detail?id=2517122854","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517122854?lang=zh_cn&edition=fundamental","pubTime":"2025-03-07 13:50","pubTimestamp":1741326632,"startTime":"0","endTime":"0","summary":"每经AI快讯，近日，康方生物（9926.HK）自主研发的全球首创PD-1/VEGF双特异性抗体新药依沃西单药对比帕博利珠单抗单药一线治疗PD-L1表达阳性（PD-L1TPS≥1%）的局部晚期或转移性非小细胞肺癌（NSCLC）的注册性Ⅲ期临床研究(HARMONi-2/AK112-303）的重磅研究数据，荣登国际顶级医学期刊《柳叶刀》（TheLancet）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503073339661294.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503073339661294.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09926","LU0348783233.USD","IE00B543WZ88.USD","LU2488822045.USD","LU0348784397.USD","IE00B5MMRT66.SGD","BK1574","IE00BPRC5H50.USD","LU0417516571.SGD","BK1161","LU1720050803.USD","LU1794554557.SGD"],"gpt_icon":0},{"id":"2517039419","title":"康方生物(09926.HK)卡度尼利治疗高复发风险肝细胞癌三期临床完成患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2517039419","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517039419?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 10:33","pubTimestamp":1741228380,"startTime":"0","endTime":"0","summary":"康方生物宣布，自主研发的全球首创PD-1/CTLA-4双抗新药卡度尼利“开坦尼”，用于高复发风险肝细胞癌根治术或消融后辅助治疗的注册性三期临床研究，近日已完成全部患者入组。目前卡度尼利配合仑伐替尼和经肝动脉化疗栓塞用于治疗中晚期不可切除HCC的注册三期临床研究也在进行中，公司预期，卡度尼利可望成为早期和中晚期HCC患者全方位且更有效率的疾病解决方案。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230531145638513_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230531145638513_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1422587/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["IE00BPRC5H50.USD","LU1794554557.SGD","LU2488822045.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU0348784397.USD","LU1720050803.USD","BK1574","BK1161","LU0348783233.USD","LU0417516571.SGD","09926"],"gpt_icon":0},{"id":"2517371939","title":"康方生物(09926)出现大手买入6.9万股，成交价$73.2，涉资505.08万","url":"https://stock-news.laohu8.com/highlight/detail?id=2517371939","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517371939?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 09:50","pubTimestamp":1741139400,"startTime":"0","endTime":"0","summary":"[大手成交]康方生物(09926)在上午09:50出现大手买入，成交量为6.9万，成交价为港币$73.2，涉资505.08万。至目前为止，股价升0.412%，今日最高价为$75.0，而最低价为$73.0，总成交量为184.559万股，总成交金额港币$1.367亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2503053019/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","09926","LU0348783233.USD","IE00BPRC5H50.USD","LU0348784397.USD","IE00B543WZ88.USD","LU1794554557.SGD","LU1720050803.USD","IE00B5MMRT66.SGD","LU0417516571.SGD","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2516257646","title":"康方生物03月04日主力净流入2016万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2516257646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516257646?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 17:38","pubTimestamp":1741081120,"startTime":"0","endTime":"0","summary":"03月04日, 康方生物股价涨1.96%，报收72.80元，成交金额4.68亿元，换手率0.73%，振幅8.54%，量比0.43。康方生物今日主力资金净流入2016万元，上一交易日主力净流出3906万元。该股近5个交易日上涨1.61%，主力资金累计净流入3733万元；近20日主力资金累计净流入1.30亿元，其中净流入天数为10日。该股主力净额占比0.03%，港股市场排名148/2648。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304174408abe79318&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304174408abe79318&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348784397.USD","IE00BPRC5H50.USD","LU1720050803.USD","IE00B543WZ88.USD","09926","BK1574","LU0348783233.USD","LU2488822045.USD","BK1161","LU1794554557.SGD","IE00B5MMRT66.SGD","LU0417516571.SGD"],"gpt_icon":0},{"id":"2516694823","title":"康方生物盘中异动 股价大跌5.46%报67.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516694823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516694823?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 09:30","pubTimestamp":1741051816,"startTime":"0","endTime":"0","summary":"2025年03月04日早盘09时30分，康方生物股票出现波动，股价快速下挫5.46%。截至发稿，该股报67.500港元/股，成交量20.2万股，换手率0.02%，振幅3.57%。资金方面，该股资金流入493.575万港元，流出416.365万港元。康方生物股票所在的生物技术行业中，整体跌幅为2.27%。其相关个股中，同源康医药-B、来凯医药-B、和誉-B涨幅较大，振幅较大的相关个股有北海康成-B、康方生物、乐普生物-B，振幅分别为4.05%、3.57%、3.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304093016abe6e616&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304093016abe6e616&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0348783233.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU1794554557.SGD","LU0417516571.SGD","IE00BPRC5H50.USD","09926","LU0348784397.USD","LU2488822045.USD","BK1574","LU1720050803.USD"],"gpt_icon":0},{"id":"2516577974","title":"国泰君安：国产创新药全球竞争力凸显 经营拐点临近","url":"https://stock-news.laohu8.com/highlight/detail?id=2516577974","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516577974?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 14:00","pubTimestamp":1740981619,"startTime":"0","endTime":"0","summary":"国泰君安主要观点如下：全球竞争力凸显，经营扭亏拐点临近国产创新药逐渐展现出全球竞争力：据医药魔方统计，2024年在中国首发获批的新药达39款，占全球近40%，全球在研first in class新药中的国产品种占比已达24%，中国企业全年license-out交易的首付款和总金额分别达41亿和519亿美元。安徽省医保局发文将牵头2025年全国生物药品联盟集采，或将包括生物类似药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09969","02611","01801","BK0201","09926","BK1587","BK0028","LU1969619763.USD","BK0188","159992","00013","BK1500","06160","LU0417516571.SGD","LU0348784397.USD","IE00BPRC5H50.USD","IE00B543WZ88.USD","LU0196878994.USD","BK1161","BK0012","IE00B5MMRT66.SGD","LU0588546209.SGD","BK0276","06990","BK1588","BK1589","BK0183","06978","LU1794554557.SGD","LU2328871848.SGD","BK1574","LU2488822045.USD","BK0184","LU1720050803.USD","LU0348783233.USD","BK1191","BK1147","BK1583","601211","BK1564","LU0307460666.USD"],"gpt_icon":0},{"id":"2516857671","title":"《大行》中金列出中资股策略首选组合(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516857671","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516857671?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 12:14","pubTimestamp":1740975240,"startTime":"0","endTime":"0","summary":"中金发表报告，列出海外中资股策略首选组合：股份腾讯 中移动 美团-W 中海油 小米-W 比亚迪 安踏 泡泡玛特 万洲中国太保 康方生物 名创优品 同程旅行 瑞声 福耀玻璃海信家电 (港股报价延迟最少十五分钟。沽空资料截至 2025-02-28 16:25。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1421557&catg=4&source=AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["XIACY","IE00B031HW06.USD","03690","LU0320764599.SGD","00921","00700","09926","00941","LU1152091168.USD","03606","LU1734074674.USD","LU0328353924.USD","80883","LU0431992006.USD","LU0531971595.HKD","LU2488822045.USD","09896","82020","BYDDY","80700","IE00B031HY20.USD","BK1227","00288","00883","BK1610","IE00B0JY6N72.USD","00780","LU0228659784.USD","LU0289960550.SGD","LU1048484197.HKD","BK1214","01810","MPNGY","81211","HTCD.SI","02601","LU1993786604.SGD","LU0828237940.HKD","002594","02018","LU2153592121.USD","81810","TCEHY","02020","LU0823038988.USD","ANPDY","HYDD.SI","01211","LU0149721374.USD","09992"],"gpt_icon":0},{"id":"2514827417","title":"【券商聚焦】中信建投予康方生物(09926)“买入”评级 指其早研管线储备丰富 具长期可持续发展能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2514827417","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514827417?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 16:30","pubTimestamp":1740645028,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投研报指，康方生物 AK112已经在NSCLC开展3项全球3期临床，本次summit与辉瑞合作将更注重在肺癌领域之外的适应症探索。公司多款在研产品及适应症即将获批上市，同时现有研发管线不断扩充丰富，早研管线储备丰富，具备长期可持续发展能力。考虑到公司创新药产品疗效优秀、市场空间广阔，给予“买入”评级。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/NWI3NDNkNGUxZmM1MTMzOTE0MzEwMTk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NWI3NDNkNGUxZmM1MTMzOTE0MzEwMTk=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1954041","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"gpt_icon":1},{"id":"2514848128","title":"《大行》建银国际降康方生物(09926.HK)目标价至85元 海外临床试验前景更明朗维持“跑赢大市”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2514848128","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514848128?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 11:48","pubTimestamp":1740628080,"startTime":"0","endTime":"0","summary":"建银国际发表报告指，对康方生物AK112的海外临床试验持更加乐观的态度。2月25日，公司美国合作伙伴Summit Therapeutics宣布，将启动AK112在美国的临床试验。AK112是康方生物已获批的针对肺部相关癌症的双特异性抗体，此次试验将与辉瑞的多种抗体药物偶联物进行联合疗法试验。建银国际对该股目标价从每股86元下调至85元，以反映对收入的较低预测和净亏损的较高预测。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200914151047405_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200914151047405_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1420680/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03347","09926"],"gpt_icon":0},{"id":"2514819406","title":"康方生物盘中异动 快速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514819406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514819406?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 09:49","pubTimestamp":1740620944,"startTime":"0","endTime":"0","summary":"2025年02月27日早盘09时49分，康方生物股票出现波动，股价快速拉升5.01%。机构评级方面，在所有16家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康方生物股票所在的生物技术行业中，整体跌幅为0.62%。消息层面，截至09时49分，《中金：维持康方生物“跑赢行业”评级 目标价90港元》资讯为影响康方生物的重要信息。除此之外，康方和Summit也有望启动更多肺癌之外的临床，进一步拓展AK112的应用范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022709490598943643&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022709490598943643&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0417516571.SGD","IE00B543WZ88.USD","LU0348783233.USD","LU2488822045.USD","09926","BK1161","BK1574","LU1720050803.USD","LU0348784397.USD","LU1794554557.SGD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2514818522","title":"【首个自研ADC澳洲临床入组 康方生物IO 2+ADC战略再进一步】近日，康方生物宣布，公司自主研发的差异化靶向人表皮生长因子受体3（HER3）ADC新药AK138D1，治疗晚期恶性肿瘤的I期临床研究在澳洲完成首例受试者入组。AK138D1是康方生物首个进入临床阶段的ADC药物。ADC药物是康方生物在全球范围内重塑治疗格局，构建肿瘤治疗新标准，以创新疗法造福全球患者的重要力量，也是康方生物推进“IO 2.0+ADC”战略的重要抓手。目前康方生物自主研发的全球首创双抗新药卡度尼利（PD-1/CTLA-4双抗）和依沃西（PD-1/VEGF双抗）均已获批上市。康方生物是全球唯一拥有2个肿瘤免疫治疗双抗的制药公司，在IO+ADC联合战略中已经建立了在肿瘤免疫端的全球领先优势。AK138D1等差异化ADC药物的开发，为康方生物充分挖掘创新产品组合的临床价值，持续迭代肿瘤疗法开拓了更广阔的空间。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514818522","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514818522?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 08:40","pubTimestamp":1740616816,"startTime":"0","endTime":"0","summary":"AK138D1是康方生物首个进入临床阶段的ADC药物。ADC药物是康方生物在全球范围内重塑治疗格局，构建肿瘤治疗新标准，以创新疗法造福全球患者的重要力量，也是康方生物推进“IO 2.0+ADC”战略的重要抓手。康方生物是全球唯一拥有2个肿瘤免疫治疗双抗的制药公司，在IO+ADC联合战略中已经建立了在肿瘤免疫端的全球领先优势。AK138D1等差异化ADC药物的开发，为康方生物充分挖掘创新产品组合的临床价值，持续迭代肿瘤疗法开拓了更广阔的空间。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27084048415964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0329678337.USD","LU0417516571.SGD","LU1169590202.USD","LU0329678170.USD","BK1191","LU1720050803.USD","BK1574","IE00B5MMRT66.SGD","BK1209","IE00BPRC5H50.USD","BK1161","IE00B543WZ88.USD","LU0348783233.USD","LU1794554557.SGD","BK1583","06078","BK4023","LU0348784397.USD","ADC","LU2488822045.USD","PD","09926","BK4231","01477","LU0737861772.HKD","BK4080","LU1169589451.USD"],"gpt_icon":0},{"id":"2514808974","title":"康方生物：HER3 ADC临床启动 IO2.0+ADC战略加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2514808974","media":"中金公司","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514808974?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 00:00","pubTimestamp":1740585600,"startTime":"0","endTime":"0","summary":"公司近况2 月27 日，公司宣布自研的HER3 ADC新药AK138D1 在澳洲启动治疗晚期恶性肿瘤的I期临床，这也是公司首个进入临床的ADC药物。评论此举是康方生物推进“IO 2.0+ADC”战略的重要抓手。康方生物作为全球唯一拥有两款上市IO双抗的公司，其通过多项大III期临床证明了两款IO双抗的临床价值，并有望通过IO2.0+ADC联合战略进一步深化公司的领先优势，为肿瘤治疗新标准迭代奠定基础。我们看好公司HER3 ADC和IO双抗的联用潜力，建议关注后续临床进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227193151a2564007&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227193151a2564007&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09926","IE00B543WZ88.USD","BK1161","LU2488822045.USD","LU0348783233.USD","LU1720050803.USD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","BK1574","LU0417516571.SGD","LU1794554557.SGD","LU0348784397.USD"],"gpt_icon":0},{"id":"2514900875","title":"港股概念追踪|百济神州成为国内“创新药一哥”  机构看好创新药2025年估值修复（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2514900875","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514900875?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 13:53","pubTimestamp":1740549201,"startTime":"0","endTime":"0","summary":"2月21日，百济神州以27亿元市值差距超越恒瑞医药，成为“创新药一哥”。百济神州的创新药收入增长迅猛，其BTK抑制剂泽布替尼全球销售额突出。百济神州市值新高有业绩支撑，预计2025年全年经营利润为正。国金证券发布研究报告称，建议继续贯彻AI医药+创新药2025年医药投资两大布局主线。该行表示，看好行业估值修复。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254498.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B5MMRT66.SGD","159992","HSCEI","ONC","LU1969619763.USD","BK1589","BK1588","09926","BK1574","06978","BK1161","LU0348784397.USD","LU0588546209.SGD","LU2328871848.SGD","688235","BK1583","YANG","01801","BK1500","LU1794554557.SGD","LU0307460666.USD","IE00BPRC5H50.USD","BK0239","LU0417516571.SGD","LU0348783233.USD","IE00B543WZ88.USD","06160","LU1720050803.USD","BK4139","HSTECH","LU2488822045.USD"],"gpt_icon":1},{"id":"2514021200","title":"【券商聚焦】交银国际维持康方生物(09926)买入评级 指PD-1双抗+ADC联用潜力值得期待","url":"https://stock-news.laohu8.com/highlight/detail?id=2514021200","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514021200?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 08:59","pubTimestamp":1740531544,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指，康方生物 依沃西将与辉瑞公司多个ADCs药物开展联合疗法临床试验：2月24日， Summit Therapeutics 宣布与辉瑞达成临床试验合作，共同推进 PD1/VEGF 双抗依沃西与辉瑞多款vedotin ADC 在多种实体瘤中的联合治疗应用。辉瑞将全面负责临床试验的开展及相关费用，Summit将提供依沃西并参与海外研究。初步临床结果显示，PD-1靶向药物能与vedotin ADC形成协同效应。该行维持买入评级和87港元目标价，并继续将公司选为行业重点推荐标的之一。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/YmUwNDEzZDkyZTQxMjdjZGQ1ZTFlYjEwODUyNTc4Njg4Nw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmUwNDEzZDkyZTQxMjdjZGQ1ZTFlYjEwODUyNTc4Njg4Nw==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1953886","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","09926","PD"],"gpt_icon":0},{"id":"2514483221","title":"康方生物(9926.HK)：合作伙伴SUMMIT与辉瑞探究联合疗法 赋能AK112全球临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2514483221","media":"中信建投证券","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514483221?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 00:00","pubTimestamp":1740499200,"startTime":"0","endTime":"0","summary":"事件康方生物/Summit AK112 与辉瑞ADC 探索联合疗法2025 年2 月24 日，康方全球合作伙伴Summit Therapeutics宣布与辉瑞开展临床合作，以评估PD-1/VEGF 双特异性抗体Ivonescimab与辉瑞的多种抗体偶联药物联合用于多种实体瘤的疗效和安全性。简评一、 合作伙伴Summit 与辉瑞达成合作，赋能AK112 全球临床研发2025 年2 月24 日，Summit Therapeutics 公布2024 年财报，披露了研发管线最新进展，同时宣布与辉瑞达成临床合作，开展PD-1/VEGF+ADC 联合治疗实体瘤的临床探索。目前依沃西在全球开展临床试验药物均由康方生物生产供应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226205145abddd28e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226205145abddd28e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","LU1794554557.SGD","IE00B5MMRT66.SGD","LU0348784397.USD","LU0417516571.SGD","IE00BPRC5H50.USD","BK1161","LU1720050803.USD","09926","IE00B543WZ88.USD","BK1574","LU0348783233.USD"],"gpt_icon":0},{"id":"2514026041","title":"康方生物：SUMMIT与PFIZER携手探索AK112联用ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2514026041","media":"中金公司","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514026041?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 00:00","pubTimestamp":1740499200,"startTime":"0","endTime":"0","summary":"公司近况2 月24 日，公司合作伙伴Summit宣布，已与辉瑞达成临床试验合作协议，共同探索AK112 和辉瑞多款ADC药物在实体瘤中的联合治疗潜力。除此之外，康方和Summit也有望启动更多肺癌之外的临床，进一步拓展AK112 的应用范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226080535abdcfe8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226080535abdcfe8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1794554557.SGD","IE00BPRC5H50.USD","09926","IE00B5MMRT66.SGD","IE00B543WZ88.USD","BK1161","BK1574","LU0348784397.USD","LU0348783233.USD","LU1720050803.USD","LU0417516571.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2514402095","title":"头对头单药击败K药后，依沃西牵手辉瑞ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2514402095","media":"医药地理","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514402095?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 17:36","pubTimestamp":1740476179,"startTime":"0","endTime":"0","summary":"依沃西+ADC联合治疗实体瘤2025年2月24日，Summit Therapeutics公布2024年财报，披露了研发管线最新进展，同时宣布与辉瑞达成临床合作，开展PD-1/VEGF依沃西+ADC联合治疗实体瘤的临床探索。伊沃西—创新药的“国货之光”伊沃西是全球首个“肿瘤免疫PD-1+抗血管VEGF”机制的双抗新药。击败K药后，依沃西临床试验最新进展Summit表示，仅在2024年，伊沃西就成为了多个医疗会议的焦点，获得了5场口头报告的机会，并发表了14篇论文，覆盖7种肿瘤类型。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225203409abdc61da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225203409abdc61da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B543WZ88.USD","09926","BK1574","03347","BK1576","IE00B5MMRT66.SGD","LU2488822045.USD","BK1141","LU0348784397.USD","BK1583","LU0417516571.SGD","LU0348783233.USD","LU1794554557.SGD","IE00BPRC5H50.USD","LU1720050803.USD","BK1161"],"gpt_icon":0},{"id":"2514034005","title":"港股异动 | 康方生物(09926)涨超5% 依沃西将与辉瑞多个ADCs药物开展联合疗法临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2514034005","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514034005?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 13:41","pubTimestamp":1740462061,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康方生物涨超5%，截至发稿，涨4.81%，报71.95港元，成交额9.44亿港元。消息面上，2月24日，康方生物宣布，依沃西国际市场开发合作伙伴Summit Therapeutics已与辉瑞达成临床试验合作，共同推进康方生物自主研发的PD-1/VEGF双抗依沃西与辉瑞多款抗体偶联药物在多种实体瘤中的联合治疗应用。公司指，此次合作的目标是深入挖掘依沃西联合辉瑞多款vedotin系列ADCs药物联合疗法在多种实体瘤中的协调潜力，加速推进可能重塑治疗格局的创新联合疗法。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253884.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4592","09926","03347","LU0868494617.USD","IE00B19Z3B42.SGD","LU1794554557.SGD","LU1894683264.USD","LU0225771236.USD","IE00BLSP4239.USD","BK4585","SG9999001176.SGD","BK4550","LU1720050803.USD","BK4581","LU0985481810.HKD","BK1574","SG9999002232.USD","PFE","LU0225284248.USD","LU0058720904.USD","BK4588","LU0289739699.SGD","LU0170899867.USD","SG9999001176.USD","LU1023059063.AUD","BK4568","SG9999011175.SGD","IE00B543WZ88.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","LU0321505439.SGD","LU0348784397.USD","LU0348783233.USD","LU0234572021.USD","BK4007","IE00BPRC5H50.USD","LU1066051498.USD","SG9999003800.SGD","SG9999002224.SGD","IE00BLSP4452.SGD","BK1576","LU0306806265.USD","SG9999013999.USD","LU0456855351.SGD","LU2488822045.USD","BK1141","SGXZ57979304.SGD","LU1894683348.USD","LU0122379950.USD","IE000M9KFDE8.USD"],"gpt_icon":0},{"id":"2514003471","title":"康方生物盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514003471","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514003471?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 13:29","pubTimestamp":1740461374,"startTime":"0","endTime":"0","summary":"2025年02月25日下午盘13时29分，康方生物股票出现波动，股价快速上涨5.03%。资金方面，该股资金流入4.7314亿港元，流出2.14278亿港元。机构评级方面，在所有15家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康方生物股票所在的生物技术行业中，整体涨幅为1.19%。康方生物公司简介：康方生物科技(开曼)有限公司是一家主要从事生物制药产品研发、生产及商业化的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502251329349891bf37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502251329349891bf37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348784397.USD","IE00BPRC5H50.USD","LU1720050803.USD","IE00B543WZ88.USD","09926","BK1574","LU0348783233.USD","LU2488822045.USD","BK1161","LU1794554557.SGD","IE00B5MMRT66.SGD","LU0417516571.SGD"],"gpt_icon":0},{"id":"2514862360","title":"康方生物(09926.HK)依沃西与辉瑞(PFE.US)ADCs药物开展联合疗法临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2514862360","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514862360?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 08:55","pubTimestamp":1740444900,"startTime":"0","endTime":"0","summary":"康方生物公布，公司自主研发的全球首创PD-1/VEGF双特异性肿瘤免疫治疗药物依沃西单抗注射液，其国际市场开发合作伙伴Summit Therapeutics已与美国辉瑞达成临床试验合作，将共同推进依沃西与辉瑞多款抗体偶联药物在多种实体瘤中的联合治疗应用。目前依沃西在全球开展临床试验药物均由康方生物生产供应。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200914151047405_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200914151047405_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1419847/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1576","IE00B543WZ88.USD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU1794554557.SGD","09926","LU0348783233.USD","03347","LU0417516571.SGD","LU0348784397.USD","LU2488822045.USD","BK1141","BK1574","BK1583","LU1720050803.USD","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09926\",params:#limit:5,,,undefined,":[{"date":"2025-03-30","symbol":"09926","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743298200000,"name":null,"time":"盘后","dateTimestamp":1743264000000,"actualEps":null},{"date":"2024-08-28","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null},{"date":"2024-03-18","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710725400000,"name":null,"time":"","dateTimestamp":1710691200000,"actualEps":null},{"date":"2023-08-29","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693272600000,"name":null,"time":"","dateTimestamp":1693238400000,"actualEps":null},{"market":"HK","date":"2023-04-27","symbol":"09926","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1682524800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09926\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09926\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.381,"buy":0.5714,"hold":0.0476,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":21,"updateTime":1745856000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09926\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09926","date":"2025-04-28","current":-143.077105,"percent":0.004946,"low":-163.883348,"twenty":-54.264543,"median":-23.982021,"eighty":13.592632,"high":20.221708,"avg":-26.032156,"sd":31.406998,"marketCap":78268555347},"quantilePoints":[{"date":"2020-04-29","current":-54.430966,"twenty":-54.873187,"median":-52.474926,"eighty":-33.645124,"marketCap":19994089211},{"date":"2020-05-08","current":-50.146246,"twenty":-54.430966,"median":-50.765107,"eighty":-50.046102,"marketCap":18429666200},{"date":"2020-05-15","current":-53.0553,"twenty":-54.153595,"median":-51.221035,"eighty":-50.046102,"marketCap":19421739329},{"date":"2020-05-22","current":-55.542078,"twenty":-56.818854,"median":-53.301351,"eighty":-50.146246,"marketCap":20266722282},{"date":"2020-05-29","current":-55.414226,"twenty":-57.202877,"median":-54.292281,"eighty":-50.518886,"marketCap":20188016564},{"date":"2020-06-05","current":-58.444689,"twenty":-58.967855,"median":-55.265323,"eighty":-50.732575,"marketCap":21447308046},{"date":"2020-06-12","current":-63.276404,"twenty":-59.542646,"median":-55.820181,"eighty":-50.765107,"marketCap":23218186692},{"date":"2020-06-19","current":-68.299799,"twenty":-60.537832,"median":-56.858534,"eighty":-51.676962,"marketCap":25107123914},{"date":"2020-06-26","current":-80.148198,"twenty":-63.334108,"median":-58.348972,"eighty":-52.779632,"marketCap":29435938382},{"date":"2020-07-03","current":-77.885169,"twenty":-66.643902,"median":-58.880358,"eighty":-53.202931,"marketCap":28648881206},{"date":"2020-07-10","current":-76.725563,"twenty":-70.305822,"median":-59.096072,"eighty":-53.649064,"marketCap":28491469771},{"date":"2020-07-17","current":-70.467076,"twenty":-73.692098,"median":-59.898011,"eighty":-54.044506,"marketCap":26209003960},{"date":"2020-07-24","current":-65.539086,"twenty":-72.620808,"median":-60.537717,"eighty":-54.320018,"marketCap":24280713879},{"date":"2020-07-31","current":-65.051015,"twenty":-71.63744,"median":-61.425183,"eighty":-54.696299,"marketCap":24241361020},{"date":"2020-08-07","current":-61.60528,"twenty":-71.199223,"median":-62.665648,"eighty":-55.108469,"marketCap":22982069539},{"date":"2020-08-14","current":-60.398898,"twenty":-70.692859,"median":-61.425183,"eighty":-55.354665,"marketCap":22588540951},{"date":"2020-08-21","current":-65.573062,"twenty":-70.162934,"median":-62.07047,"eighty":-55.490937,"marketCap":24634889608},{"date":"2020-08-28","current":-62.258841,"twenty":-69.624858,"median":-61.507641,"eighty":-55.875802,"marketCap":23572362421},{"date":"2020-09-04","current":-56.454938,"twenty":-69.299363,"median":-61.279481,"eighty":-56.312276,"marketCap":21447308046},{"date":"2020-09-11","current":-59.39532,"twenty":-69.034548,"median":-61.149297,"eighty":-56.381895,"marketCap":22588540951},{"date":"2020-09-18","current":-23.213534,"twenty":-68.783672,"median":-61.157004,"eighty":-56.381895,"marketCap":23847832432},{"date":"2020-09-25","current":-20.580693,"twenty":-68.608413,"median":-60.769842,"eighty":-55.354665,"marketCap":20975073740},{"date":"2020-09-30","current":-21.520592,"twenty":-68.49576,"median":-60.537717,"eighty":-54.51941,"marketCap":22037600928},{"date":"2020-10-09","current":-20.533232,"twenty":-68.261016,"median":-60.351714,"eighty":-53.10451,"marketCap":21329249469},{"date":"2020-10-16","current":-20.579561,"twenty":-67.599319,"median":-60.014098,"eighty":-50.561624,"marketCap":21368602328},{"date":"2020-10-23","current":-18.390768,"twenty":-65.566444,"median":-59.898011,"eighty":-36.752532,"marketCap":19125489376},{"date":"2020-10-30","current":-18.387929,"twenty":-65.53997,"median":-59.39532,"eighty":-22.333682,"marketCap":19125489376},{"date":"2020-11-06","current":-18.960772,"twenty":-65.539086,"median":-59.096072,"eighty":-21.714319,"marketCap":19951899411},{"date":"2020-11-13","current":-17.861227,"twenty":-65.495719,"median":-58.967855,"eighty":-21.20377,"marketCap":18810666506},{"date":"2020-11-20","current":-18.195519,"twenty":-65.439452,"median":-58.396831,"eighty":-20.827083,"marketCap":19282900812},{"date":"2020-11-27","current":-18.163703,"twenty":-65.051015,"median":-57.55027,"eighty":-20.533232,"marketCap":19204195094},{"date":"2020-12-04","current":-19.807773,"twenty":-64.515903,"median":-57.279422,"eighty":-20.022532,"marketCap":21093132316},{"date":"2020-12-11","current":-21.33702,"twenty":-64.452305,"median":-56.818854,"eighty":-20.137955,"marketCap":22667246668},{"date":"2020-12-18","current":-24.630996,"twenty":-64.186949,"median":-56.363634,"eighty":-20.421683,"marketCap":26209003960},{"date":"2020-12-24","current":-26.970119,"twenty":-63.818518,"median":-55.820181,"eighty":-20.432553,"marketCap":28727586924},{"date":"2020-12-31","current":-28.06698,"twenty":-63.629518,"median":-55.339775,"eighty":-20.494047,"marketCap":29908172688},{"date":"2021-01-08","current":-32.570823,"twenty":-63.597221,"median":-55.265323,"eighty":-20.51364,"marketCap":34984691473},{"date":"2021-01-15","current":-37.631162,"twenty":-63.40952,"median":-54.292281,"eighty":-20.570295,"marketCap":40403477353},{"date":"2021-01-22","current":-41.643907,"twenty":-63.295257,"median":-53.301351,"eighty":-20.580467,"marketCap":44693027527},{"date":"2021-01-29","current":-40.849406,"twenty":-63.217929,"median":-51.221035,"eighty":-20.705895,"marketCap":44202793221},{"date":"2021-02-05","current":-42.462881,"twenty":-63.20331,"median":-50.765107,"eighty":-20.737196,"marketCap":45673496138},{"date":"2021-02-11","current":-44.298428,"twenty":-63.199738,"median":-50.518886,"eighty":-20.809106,"marketCap":47716139078},{"date":"2021-02-19","current":-44.620302,"twenty":-63.148699,"median":-50.046102,"eighty":-20.827888,"marketCap":48083814807},{"date":"2021-02-26","current":-38.677591,"twenty":-62.923489,"median":-46.003712,"eighty":-21.003278,"marketCap":41588210258},{"date":"2021-03-05","current":-36.070462,"twenty":-62.63965,"median":-44.620302,"eighty":-21.129156,"marketCap":38687657283},{"date":"2021-03-12","current":-33.577269,"twenty":-62.438134,"median":-44.247826,"eighty":-21.158012,"marketCap":35950515744},{"date":"2021-03-19","current":-35.993074,"twenty":-62.327407,"median":-43.908841,"eighty":-21.185375,"marketCap":38524245848},{"date":"2021-03-26","current":-37.072786,"twenty":-62.202297,"median":-42.138278,"eighty":-21.221991,"marketCap":39504714459},{"date":"2021-04-01","current":-41.283195,"twenty":-62.015041,"median":-41.751169,"eighty":-21.266862,"marketCap":43875970351},{"date":"2021-04-09","current":-31.196593,"twenty":-61.70772,"median":-41.695813,"eighty":-21.319481,"marketCap":43590000339},{"date":"2021-04-16","current":-30.642009,"twenty":-61.527169,"median":-40.849406,"eighty":-21.393706,"marketCap":42977207457},{"date":"2021-04-23","current":-31.96013,"twenty":-61.441675,"median":-40.344151,"eighty":-21.433299,"marketCap":44938144680},{"date":"2021-04-30","current":-30.816187,"twenty":-61.312504,"median":-39.558199,"eighty":-21.441654,"marketCap":43508294622},{"date":"2021-05-07","current":-28.864106,"twenty":-61.27851,"median":-38.69692,"eighty":-21.489217,"marketCap":41016270235},{"date":"2021-05-14","current":-29.343194,"twenty":-61.208677,"median":-38.024901,"eighty":-21.636828,"marketCap":41669915976},{"date":"2021-05-21","current":-32.815059,"twenty":-61.158545,"median":-37.656345,"eighty":-21.839766,"marketCap":46613111890},{"date":"2021-05-28","current":-34.118192,"twenty":-61.102433,"median":-37.609185,"eighty":-22.049324,"marketCap":48941724842},{"date":"2021-06-04","current":-35.625611,"twenty":-60.979677,"median":-37.553441,"eighty":-22.116923,"marketCap":50861809206},{"date":"2021-06-10","current":-37.08623,"twenty":-60.769842,"median":-37.072786,"eighty":-22.258985,"marketCap":52986157863},{"date":"2021-06-18","current":-35.659842,"twenty":-60.584234,"median":-36.485136,"eighty":-22.270088,"marketCap":50494133476},{"date":"2021-06-25","current":-36.773665,"twenty":-60.537647,"median":-36.47778,"eighty":-22.279086,"marketCap":51923983534},{"date":"2021-06-30","current":-36.160141,"twenty":-60.48212,"median":-36.485136,"eighty":-22.301737,"marketCap":51188632076},{"date":"2021-07-09","current":-33.001535,"twenty":-60.380024,"median":-36.358401,"eighty":-22.333501,"marketCap":46572259032},{"date":"2021-07-16","current":-33.61015,"twenty":-60.247205,"median":-36.160141,"eighty":-22.684742,"marketCap":47430169066},{"date":"2021-07-23","current":-30.660269,"twenty":-60.081955,"median":-36.081197,"eighty":-23.212212,"marketCap":43263177469},{"date":"2021-07-30","current":-29.749657,"twenty":-60.025123,"median":-35.993074,"eighty":-23.780519,"marketCap":42119297422},{"date":"2021-08-06","current":-26.92917,"twenty":-59.948494,"median":-35.665203,"eighty":-24.743522,"marketCap":38034011542},{"date":"2021-08-13","current":-25.592675,"twenty":-59.918873,"median":-35.597545,"eighty":-24.965673,"marketCap":36195632896},{"date":"2021-08-20","current":-20.885732,"twenty":-59.826938,"median":-35.459665,"eighty":-24.434422,"marketCap":29454911194},{"date":"2021-08-27","current":-21.082492,"twenty":-59.613719,"median":-35.394103,"eighty":-23.176546,"marketCap":29863439782},{"date":"2021-09-03","current":-31.115126,"twenty":-59.45425,"median":-35.211108,"eighty":-23.023412,"marketCap":34806635697},{"date":"2021-09-10","current":-32.055246,"twenty":-59.359698,"median":-34.971061,"eighty":-23.122707,"marketCap":35950515744},{"date":"2021-09-17","current":-31.163903,"twenty":-59.210176,"median":-34.572405,"eighty":-23.198629,"marketCap":34847488556},{"date":"2021-09-24","current":-31.295563,"twenty":-59.102123,"median":-34.437371,"eighty":-23.212212,"marketCap":35010899991},{"date":"2021-09-30","current":-31.154784,"twenty":-59.047908,"median":-34.407249,"eighty":-23.447883,"marketCap":34970047132},{"date":"2021-10-08","current":-29.845898,"twenty":-58.976264,"median":-34.085183,"eighty":-24.385279,"marketCap":33499344216},{"date":"2021-10-15","current":-32.807984,"twenty":-58.969537,"median":-33.89682,"eighty":-24.581853,"marketCap":36849278637},{"date":"2021-10-22","current":-33.585285,"twenty":-58.897857,"median":-33.786096,"eighty":-24.856047,"marketCap":37993158684},{"date":"2021-10-29","current":-31.568779,"twenty":-58.531823,"median":-33.627637,"eighty":-25.019036,"marketCap":35623692873},{"date":"2021-11-05","current":-28.336247,"twenty":-58.387259,"median":-33.581277,"eighty":-25.13981,"marketCap":32028641299},{"date":"2021-11-12","current":-31.135474,"twenty":-58.165915,"median":-33.566565,"eighty":-25.305935,"marketCap":35337722862},{"date":"2021-11-19","current":-36.658551,"twenty":-57.747713,"median":-33.576384,"eighty":-25.505551,"marketCap":41547357399},{"date":"2021-11-26","current":-34.737009,"twenty":-57.465203,"median":-33.61015,"eighty":-25.671516,"marketCap":39382155883},{"date":"2021-12-03","current":-31.939354,"twenty":-57.376977,"median":-33.627637,"eighty":-26.141756,"marketCap":36277338614},{"date":"2021-12-10","current":-30.771813,"twenty":-57.264113,"median":-33.577269,"eighty":-26.43668,"marketCap":35010899991},{"date":"2021-12-17","current":-26.05017,"twenty":-56.996271,"median":-33.456271,"eighty":-26.43668,"marketCap":29618322630},{"date":"2021-12-24","current":-24.338156,"twenty":-56.834726,"median":-33.106388,"eighty":-25.505551,"marketCap":27698238266},{"date":"2021-12-31","current":-24.356969,"twenty":-56.799582,"median":-33.044261,"eighty":-25.17902,"marketCap":27779943984},{"date":"2022-01-07","current":-20.242995,"twenty":-23.086945,"median":-21.779811,"eighty":-19.899701,"marketCap":23000159504},{"date":"2022-01-14","current":-20.701287,"twenty":-22.600464,"median":-21.033383,"eighty":-20.391327,"marketCap":23572099527},{"date":"2022-01-21","current":-18.577865,"twenty":-21.986595,"median":-20.680988,"eighty":-19.350843,"marketCap":21202633717},{"date":"2022-01-28","current":-14.534275,"twenty":-21.562934,"median":-20.260299,"eighty":-18.52558,"marketCap":16545407814},{"date":"2022-02-04","current":-14.146452,"twenty":-21.41835,"median":-20.123216,"eighty":-17.613539,"marketCap":16096026367},{"date":"2022-02-11","current":-13.816944,"twenty":-21.209422,"median":-19.299968,"eighty":-14.985471,"marketCap":15752862353},{"date":"2022-02-18","current":-13.849256,"twenty":-20.857344,"median":-18.911796,"eighty":-14.543623,"marketCap":15867250357},{"date":"2022-02-25","current":-14.199347,"twenty":-20.701287,"median":-17.613539,"eighty":-14.146452,"marketCap":16308461232},{"date":"2022-03-04","current":-14.080132,"twenty":-20.680988,"median":-15.318994,"eighty":-14.146452,"marketCap":16177732084},{"date":"2022-03-11","current":-11.936356,"twenty":-20.490215,"median":-14.985471,"eighty":-13.996814,"marketCap":13693878269},{"date":"2022-03-18","current":-11.726724,"twenty":-20.277602,"median":-14.700549,"eighty":-13.379502,"marketCap":13399737686},{"date":"2022-03-25","current":-12.670051,"twenty":-20.242995,"median":-14.554967,"eighty":-13.072377,"marketCap":14478253158},{"date":"2022-04-01","current":-9.59311,"twenty":-20.003436,"median":-14.538949,"eighty":-12.331764,"marketCap":12697068515},{"date":"2022-04-08","current":-10.156641,"twenty":-19.508494,"median":-14.196743,"eighty":-11.833638,"marketCap":13448761116},{"date":"2022-04-14","current":-9.530673,"twenty":-19.333884,"median":-14.131899,"eighty":-11.51878,"marketCap":12599021653},{"date":"2022-04-22","current":-8.780037,"twenty":-19.299831,"median":-14.060726,"eighty":-10.573986,"marketCap":11389777033},{"date":"2022-04-29","current":-9.576611,"twenty":-19.278065,"median":-13.849256,"eighty":-10.115287,"marketCap":12223175352},{"date":"2022-05-06","current":-7.86231,"twenty":-19.112154,"median":-13.498553,"eighty":-9.579911,"marketCap":9951756403},{"date":"2022-05-13","current":-8.110711,"twenty":-18.577865,"median":-13.379502,"eighty":-9.437455,"marketCap":10082485551},{"date":"2022-05-20","current":-9.061494,"twenty":-18.447152,"median":-13.096379,"eighty":-8.947629,"marketCap":11422459320},{"date":"2022-05-27","current":-8.809867,"twenty":-17.613539,"median":-12.670051,"eighty":-8.780037,"marketCap":11095636450},{"date":"2022-06-02","current":-11.227787,"twenty":-16.802517,"median":-12.331764,"eighty":-8.803901,"marketCap":14216794862},{"date":"2022-06-10","current":-12.109337,"twenty":-15.675042,"median":-12.221978,"eighty":-8.825148,"marketCap":15229945760},{"date":"2022-06-17","current":-11.667379,"twenty":-15.244074,"median":-11.936356,"eighty":-8.923897,"marketCap":14658005737},{"date":"2022-06-24","current":-16.485913,"twenty":-15.494316,"median":-12.221978,"eighty":-9.038721,"marketCap":20794105129},{"date":"2022-06-30","current":-14.957001,"twenty":-15.895364,"median":-12.380422,"eighty":-9.079607,"marketCap":18833167906},{"date":"2022-07-08","current":-15.913959,"twenty":-16.531452,"median":-12.638751,"eighty":-9.104893,"marketCap":20058753670},{"date":"2022-07-15","current":-15.322331,"twenty":-16.45611,"median":-12.887919,"eighty":-9.149933,"marketCap":19134050754},{"date":"2022-07-22","current":-14.807486,"twenty":-16.221667,"median":-13.200862,"eighty":-9.216155,"marketCap":18503257872},{"date":"2022-07-29","current":-14.117198,"twenty":-15.979822,"median":-13.449665,"eighty":-9.360153,"marketCap":17662200696},{"date":"2022-08-05","current":-15.298986,"twenty":-15.838747,"median":-13.498553,"eighty":-9.442,"marketCap":19091997895},{"date":"2022-08-12","current":-15.143556,"twenty":-15.77936,"median":-13.923035,"eighty":-9.496416,"marketCap":18923786460},{"date":"2022-08-19","current":-14.616817,"twenty":-15.77936,"median":-14.080132,"eighty":-9.558236,"marketCap":18082729284},{"date":"2022-08-26","current":-14.756101,"twenty":-15.738632,"median":-14.060726,"eighty":-9.58651,"marketCap":21573116564},{"date":"2022-09-02","current":-14.751536,"twenty":-15.714766,"median":-14.080132,"eighty":-9.724865,"marketCap":21489010846},{"date":"2022-09-09","current":-14.98178,"twenty":-15.703366,"median":-14.105484,"eighty":-9.977712,"marketCap":21741327999},{"date":"2022-09-16","current":-13.542084,"twenty":-15.658514,"median":-14.086951,"eighty":-10.115287,"marketCap":19470473624},{"date":"2022-09-23","current":-12.107338,"twenty":-15.550768,"median":-14.041319,"eighty":-10.199224,"marketCap":17073460672},{"date":"2022-09-30","current":-12.91765,"twenty":-15.461818,"median":-13.978573,"eighty":-10.287783,"marketCap":18250940719},{"date":"2022-10-07","current":-16.281937,"twenty":-15.588998,"median":-14.018764,"eighty":-10.343921,"marketCap":23002913763},{"date":"2022-10-14","current":-15.674276,"twenty":-15.588998,"median":-14.040715,"eighty":-10.440625,"marketCap":21909539434},{"date":"2022-10-21","current":-18.781307,"twenty":-15.710601,"median":-14.070137,"eighty":-10.570074,"marketCap":26072772456},{"date":"2022-10-28","current":-18.085263,"twenty":-15.888888,"median":-14.117198,"eighty":-10.76408,"marketCap":25063503844},{"date":"2022-11-04","current":-18.001131,"twenty":-16.380537,"median":-14.170295,"eighty":-10.773453,"marketCap":25189662421},{"date":"2022-11-11","current":-17.246398,"twenty":-16.644748,"median":-14.199347,"eighty":-10.843556,"marketCap":24348605245},{"date":"2022-11-18","current":-21.310798,"twenty":-17.050284,"median":-14.308051,"eighty":-11.043704,"marketCap":29983688324},{"date":"2022-11-25","current":-18.980602,"twenty":-17.498612,"median":-14.382807,"eighty":-11.22006,"marketCap":26493301044},{"date":"2022-12-02","current":-19.013979,"twenty":-17.995008,"median":-14.534799,"eighty":-11.242055,"marketCap":26997935349},{"date":"2022-12-09","current":-24.062263,"twenty":-18.437795,"median":-14.543856,"eighty":-11.359054,"marketCap":34483344216},{"date":"2022-12-16","current":-24.530301,"twenty":-18.889555,"median":-14.574904,"eighty":-11.602588,"marketCap":35072084239},{"date":"2022-12-23","current":-25.228352,"twenty":-19.041941,"median":-14.612379,"eighty":-11.627361,"marketCap":36081352850},{"date":"2022-12-30","current":-24.983629,"twenty":-19.09779,"median":-14.616563,"eighty":-11.655751,"marketCap":36165458568},{"date":"2023-01-06","current":-26.109825,"twenty":-19.246994,"median":-14.727609,"eighty":-11.666513,"marketCap":38183995790},{"date":"2023-01-13","current":-27.482086,"twenty":-19.35432,"median":-14.788719,"eighty":-11.675194,"marketCap":40959484471},{"date":"2023-01-20","current":-27.207673,"twenty":-19.72973,"median":-14.927803,"eighty":-11.681264,"marketCap":40202533012},{"date":"2023-01-27","current":-29.02317,"twenty":-19.973183,"median":-14.953302,"eighty":-11.681837,"marketCap":42893915976},{"date":"2023-02-03","current":-27.684735,"twenty":-20.135985,"median":-14.979187,"eighty":-11.694899,"marketCap":41127695906},{"date":"2023-02-10","current":-25.345976,"twenty":-20.490215,"median":-14.987339,"eighty":-11.726724,"marketCap":37427044332},{"date":"2023-02-17","current":-24.322978,"twenty":-20.857344,"median":-15.034554,"eighty":-11.784491,"marketCap":35576718544},{"date":"2023-02-24","current":-24.100109,"twenty":-21.41835,"median":-15.060613,"eighty":-11.860367,"marketCap":34819767086},{"date":"2023-03-03","current":-25.36278,"twenty":-22.807081,"median":-15.131721,"eighty":-11.936356,"marketCap":36880357167},{"date":"2023-03-10","current":-22.900092,"twenty":-23.768741,"median":-23.203261,"eighty":-23.03994,"marketCap":33053547016},{"date":"2023-03-17","current":-29.09369,"twenty":-36.802165,"median":-25.36278,"eighty":-15.020812,"marketCap":38688630096},{"date":"2023-03-24","current":-25.324343,"twenty":-36.777216,"median":-25.389232,"eighty":-15.036479,"marketCap":34062815628},{"date":"2023-03-31","current":-25.456261,"twenty":-36.704597,"median":-25.488573,"eighty":-15.049117,"marketCap":33978709910},{"date":"2023-04-06","current":-27.774061,"twenty":-36.623868,"median":-25.540624,"eighty":-15.058257,"marketCap":37048568602},{"date":"2023-04-14","current":-29.730818,"twenty":-36.485136,"median":-25.637411,"eighty":-15.064541,"marketCap":39697898707},{"date":"2023-04-21","current":-26.784111,"twenty":-36.470425,"median":-25.724076,"eighty":-15.129637,"marketCap":35744929980},{"date":"2023-04-28","current":-27.207269,"twenty":-36.436465,"median":-26.010547,"eighty":-15.131721,"marketCap":36039299991},{"date":"2023-05-05","current":-28.335447,"twenty":-36.311562,"median":-26.064869,"eighty":-15.141189,"marketCap":37595255767},{"date":"2023-05-12","current":-27.159579,"twenty":-36.18971,"median":-26.086367,"eighty":-15.143863,"marketCap":35786982838},{"date":"2023-05-19","current":-24.342298,"twenty":-36.161524,"median":-26.085247,"eighty":-15.156,"marketCap":31623749817},{"date":"2023-05-25","current":-24.063272,"twenty":-36.158475,"median":-26.064869,"eighty":-15.180082,"marketCap":31203221229},{"date":"2023-06-02","current":-23.645458,"twenty":-36.149195,"median":-25.984476,"eighty":-15.257042,"marketCap":30488322630},{"date":"2023-06-09","current":-23.222359,"twenty":-36.112659,"median":-25.723039,"eighty":-15.312993,"marketCap":29899582606},{"date":"2023-06-16","current":-24.58122,"twenty":-36.07905,"median":-25.633881,"eighty":-15.343575,"marketCap":31497591241},{"date":"2023-06-23","current":-21.944137,"twenty":-36.043198,"median":-25.488573,"eighty":-15.365065,"marketCap":27965151102},{"date":"2023-06-30","current":-23.543047,"twenty":-35.998611,"median":-25.389232,"eighty":-15.403178,"marketCap":29731371171},{"date":"2023-07-07","current":-23.989446,"twenty":-35.969849,"median":-25.36278,"eighty":-15.455833,"marketCap":30236005477},{"date":"2023-07-14","current":-24.41425,"twenty":-35.912278,"median":-25.312393,"eighty":-15.498928,"marketCap":31203221229},{"date":"2023-07-21","current":-24.59436,"twenty":-35.843663,"median":-25.202538,"eighty":-15.562817,"marketCap":31287326947},{"date":"2023-07-28","current":-28.426335,"twenty":-35.766034,"median":-25.264398,"eighty":-15.623426,"marketCap":36123405709},{"date":"2023-08-04","current":-24.11733,"twenty":-35.704573,"median":-25.300444,"eighty":-15.66297,"marketCap":30698586924},{"date":"2023-08-11","current":-22.294,"twenty":-35.666275,"median":-25.201022,"eighty":-15.683018,"marketCap":28217468254},{"date":"2023-08-18","current":-21.752014,"twenty":-35.64615,"median":-25.173816,"eighty":-15.703366,"marketCap":27334358220},{"date":"2023-08-25","current":-22.10921,"twenty":-35.616771,"median":-25.07893,"eighty":-15.714766,"marketCap":27796939666},{"date":"2023-09-01","current":13.494719,"twenty":-35.601124,"median":-25.008455,"eighty":-15.66297,"marketCap":28974419713},{"date":"2023-09-08","current":13.695117,"twenty":-35.550756,"median":-24.944029,"eighty":-15.455833,"marketCap":29058525430},{"date":"2023-09-15","current":14.848421,"twenty":-35.47221,"median":-24.903626,"eighty":-15.308324,"marketCap":31749908394},{"date":"2023-09-22","current":14.814862,"twenty":-35.438003,"median":-24.827647,"eighty":-15.14371,"marketCap":31539644100},{"date":"2023-09-29","current":14.197918,"twenty":-35.396385,"median":-24.772153,"eighty":-15.059828,"marketCap":30278058336},{"date":"2023-10-06","current":13.889059,"twenty":-35.370319,"median":-24.700469,"eighty":-15.007069,"marketCap":29605212595},{"date":"2023-10-13","current":15.431226,"twenty":-35.30592,"median":-24.632761,"eighty":-14.979706,"marketCap":32843282722},{"date":"2023-10-20","current":14.94053,"twenty":-35.232247,"median":-24.59436,"eighty":-14.914724,"marketCap":31749908394},{"date":"2023-10-27","current":16.35255,"twenty":-35.175876,"median":-24.58122,"eighty":-14.756101,"marketCap":34735661368},{"date":"2023-11-03","current":17.592659,"twenty":-35.129074,"median":-24.511377,"eighty":-14.616308,"marketCap":37469097190},{"date":"2023-11-10","current":18.939266,"twenty":-34.971061,"median":-24.417444,"eighty":-14.569406,"marketCap":40328691589},{"date":"2023-11-17","current":18.319814,"twenty":-34.968612,"median":-24.399566,"eighty":-14.535322,"marketCap":39361475836},{"date":"2023-11-24","current":18.189638,"twenty":-34.895357,"median":-24.342298,"eighty":-14.371526,"marketCap":39403528695},{"date":"2023-12-01","current":18.752497,"twenty":-34.737009,"median":-24.330293,"eighty":-14.199347,"marketCap":40791273036},{"date":"2023-12-08","current":16.771041,"twenty":-34.685609,"median":-24.255162,"eighty":-14.117346,"marketCap":36333670003},{"date":"2023-12-15","current":17.832719,"twenty":-34.615488,"median":-24.15298,"eighty":-14.060142,"marketCap":38856841531},{"date":"2023-12-22","current":16.203086,"twenty":-34.602221,"median":-24.100109,"eighty":-13.960331,"marketCap":35282348533},{"date":"2023-12-29","current":17.826838,"twenty":-34.566441,"median":-24.075355,"eighty":-13.84838,"marketCap":39025052966},{"date":"2024-01-05","current":16.831364,"twenty":-34.502078,"median":-24.025855,"eighty":-13.7643,"marketCap":36585987156},{"date":"2024-01-12","current":17.634525,"twenty":-34.43816,"median":-23.91516,"eighty":-13.515965,"marketCap":38352207225},{"date":"2024-01-19","current":16.051677,"twenty":-34.428025,"median":-23.817977,"eighty":-13.388012,"marketCap":34861819945},{"date":"2024-01-26","current":16.269899,"twenty":-34.417805,"median":-23.667454,"eighty":-13.261099,"marketCap":35198242815},{"date":"2024-02-02","current":15.531605,"twenty":-34.408725,"median":-23.587311,"eighty":-13.092715,"marketCap":33558181322},{"date":"2024-02-09","current":15.823479,"twenty":-34.287198,"median":-23.509747,"eighty":-12.88456,"marketCap":34357185639},{"date":"2024-02-16","current":17.001239,"twenty":-34.118192,"median":-23.29296,"eighty":-12.670051,"marketCap":36922410026},{"date":"2024-02-23","current":17.733723,"twenty":-34.052175,"median":-23.261464,"eighty":-12.429079,"marketCap":38310154366},{"date":"2024-03-01","current":18.170113,"twenty":-33.918444,"median":-23.222586,"eighty":-12.109337,"marketCap":39277370119},{"date":"2024-03-08","current":18.375936,"twenty":-33.875196,"median":-23.212231,"eighty":-11.784491,"marketCap":39739951566},{"date":"2024-03-15","current":20.221708,"twenty":-33.786096,"median":-23.186995,"eighty":-11.680404,"marketCap":43692920293},{"date":"2024-03-22","current":17.596046,"twenty":-33.777607,"median":-23.165857,"eighty":-11.598761,"marketCap":38772735813},{"date":"2024-03-28","current":17.863111,"twenty":-33.671621,"median":-23.133172,"eighty":-11.174522,"marketCap":39235317260},{"date":"2024-04-05","current":17.790526,"twenty":-33.631134,"median":-23.073507,"eighty":-10.781195,"marketCap":39050158637},{"date":"2024-04-12","current":19.515107,"twenty":-33.600204,"median":-23.002422,"eighty":-10.363031,"marketCap":42859930212},{"date":"2024-04-19","current":17.322126,"twenty":-33.582079,"median":-22.887987,"eighty":-9.922708,"marketCap":38011130026},{"date":"2024-04-26","current":19.239838,"twenty":-33.576561,"median":-22.815578,"eighty":-9.479287,"marketCap":42167244471},{"date":"2024-05-03","current":19.371749,"twenty":-33.573712,"median":-22.807081,"eighty":-9.18811,"marketCap":42427001624},{"date":"2024-05-10","current":19.700553,"twenty":-33.522448,"median":-22.755385,"eighty":-8.970402,"marketCap":43249565941},{"date":"2024-05-17","current":19.23578,"twenty":-33.345978,"median":-22.735553,"eighty":-8.780037,"marketCap":42167244471},{"date":"2024-05-24","current":14.667701,"twenty":-33.217784,"median":-22.607363,"eighty":-8.675073,"marketCap":32080008370},{"date":"2024-05-31","current":17.401421,"twenty":-33.106388,"median":-22.460124,"eighty":-8.554056,"marketCap":38097715744},{"date":"2024-06-07","current":16.096502,"twenty":-33.061925,"median":-22.417733,"eighty":-8.291628,"marketCap":35197094204},{"date":"2024-06-14","current":15.794192,"twenty":-33.047794,"median":-22.339227,"eighty":-8.117822,"marketCap":34504408463},{"date":"2024-06-21","current":14.159201,"twenty":-33.01008,"median":-22.315076,"eighty":-7.860137,"marketCap":30867808324},{"date":"2024-06-28","current":14.999486,"twenty":-32.90826,"median":-22.280642,"eighty":13.494356,"marketCap":32686108394},{"date":"2024-07-05","current":15.459781,"twenty":-32.881624,"median":-22.258985,"eighty":13.627238,"marketCap":33681844146},{"date":"2024-07-12","current":15.952998,"twenty":-32.86657,"median":-22.065202,"eighty":13.703744,"marketCap":34807458475},{"date":"2024-07-19","current":15.972541,"twenty":-32.832239,"median":-21.944137,"eighty":13.863497,"marketCap":34850751334},{"date":"2024-07-26","current":16.071567,"twenty":-32.814226,"median":-21.7966,"eighty":14.148348,"marketCap":35197094204},{"date":"2024-08-02","current":16.61499,"twenty":-32.811697,"median":-21.752014,"eighty":14.411832,"marketCap":36366001392},{"date":"2024-08-09","current":17.212345,"twenty":-32.808943,"median":-21.597174,"eighty":14.509977,"marketCap":37924544308},{"date":"2024-08-16","current":17.657405,"twenty":-32.804956,"median":-21.439655,"eighty":14.640353,"marketCap":38920280061},{"date":"2024-08-23","current":17.9547,"twenty":-32.79969,"median":-21.418042,"eighty":14.703604,"marketCap":39742844378},{"date":"2024-08-30","current":-52.624506,"twenty":-32.804956,"median":-21.417734,"eighty":14.818346,"marketCap":42513587341},{"date":"2024-09-06","current":-51.635037,"twenty":-32.832239,"median":-21.438942,"eighty":14.78042,"marketCap":41734315883},{"date":"2024-09-13","current":-66.216902,"twenty":-33.018625,"median":-21.520592,"eighty":14.703604,"marketCap":53380094900},{"date":"2024-09-20","current":-69.932725,"twenty":-33.173226,"median":-21.714319,"eighty":14.662246,"marketCap":56713645028},{"date":"2024-09-27","current":-71.531113,"twenty":-33.576561,"median":-21.771586,"eighty":14.652247,"marketCap":58358773662},{"date":"2024-10-04","current":-79.320454,"twenty":-33.638129,"median":-21.813706,"eighty":14.649255,"marketCap":64419773894},{"date":"2024-10-10","current":-69.213885,"twenty":-33.875196,"median":-21.986037,"eighty":14.648182,"marketCap":55847787852},{"date":"2024-10-18","current":-74.646599,"twenty":-34.399868,"median":-22.081407,"eighty":14.635134,"marketCap":59917316579},{"date":"2024-10-25","current":-77.719883,"twenty":-34.441314,"median":-22.265924,"eighty":14.560741,"marketCap":62380223732},{"date":"2024-11-01","current":-76.214752,"twenty":-34.685609,"median":-22.294,"eighty":14.556702,"marketCap":61213399403},{"date":"2024-11-08","current":-76.2814,"twenty":-34.971061,"median":-22.333531,"eighty":14.515997,"marketCap":60989010109},{"date":"2024-11-15","current":-78.00551,"twenty":-35.320815,"median":-22.40582,"eighty":14.505964,"marketCap":61707055850},{"date":"2024-11-22","current":-81.958791,"twenty":-35.480573,"median":-22.437728,"eighty":14.479729,"marketCap":64803628107},{"date":"2024-11-29","current":-83.036127,"twenty":-35.659842,"median":-22.470599,"eighty":14.463817,"marketCap":65611429565},{"date":"2024-12-06","current":-74.237179,"twenty":-35.878177,"median":-22.720101,"eighty":14.435399,"marketCap":58520727875},{"date":"2024-12-13","current":-72.615659,"twenty":-36.070462,"median":-22.745547,"eighty":14.396121,"marketCap":57129514252},{"date":"2024-12-20","current":-69.730236,"twenty":-36.160141,"median":-22.79318,"eighty":14.28027,"marketCap":54616354159},{"date":"2024-12-27","current":-68.121477,"twenty":-36.342788,"median":-22.81524,"eighty":14.230859,"marketCap":53314896254},{"date":"2025-01-03","current":-66.794572,"twenty":-36.589185,"median":-22.863096,"eighty":14.182431,"marketCap":52327583360},{"date":"2025-01-10","current":-64.575988,"twenty":-36.921451,"median":-22.916115,"eighty":14.151966,"marketCap":50397835432},{"date":"2025-01-17","current":-67.97132,"twenty":-37.388459,"median":-23.037405,"eighty":14.124517,"marketCap":53090506960},{"date":"2025-01-24","current":-71.487894,"twenty":-37.630978,"median":-23.112092,"eighty":14.06824,"marketCap":56187079217},{"date":"2025-01-28","current":-69.159217,"twenty":-37.749998,"median":-23.133265,"eighty":14.036856,"marketCap":54616354159},{"date":"2025-02-07","current":-74.204707,"twenty":-38.720974,"median":-23.179575,"eighty":13.91548,"marketCap":58296338581},{"date":"2025-02-14","current":-68.942526,"twenty":-39.742666,"median":-23.199597,"eighty":13.854976,"marketCap":54032941995},{"date":"2025-02-21","current":-78.532535,"twenty":-40.936164,"median":-23.213534,"eighty":13.833941,"marketCap":61886567285},{"date":"2025-02-28","current":-83.363188,"twenty":-41.78603,"median":-23.229233,"eighty":13.752998,"marketCap":65476795989},{"date":"2025-03-07","current":-82.972913,"twenty":-43.765472,"median":-23.273351,"eighty":13.720056,"marketCap":65431918130},{"date":"2025-03-14","current":-81.918752,"twenty":-44.36559,"median":-23.404228,"eighty":13.69943,"marketCap":64624116672},{"date":"2025-03-21","current":-77.113549,"twenty":-46.703645,"median":-23.571971,"eighty":13.681934,"marketCap":60809498674},{"date":"2025-03-28","current":-85.082441,"twenty":-50.561624,"median":-23.656456,"eighty":13.67268,"marketCap":66957765329},{"date":"2025-04-03","current":-139.968555,"twenty":-51.651807,"median":-23.75284,"eighty":13.662257,"marketCap":77100161418},{"date":"2025-04-11","current":-135.149196,"twenty":-52.531592,"median":-23.854164,"eighty":13.627238,"marketCap":73779199867},{"date":"2025-04-17","current":-136.201828,"twenty":-53.202931,"median":-23.974596,"eighty":13.597708,"marketCap":74452367749},{"date":"2025-04-25","current":-162.080631,"twenty":-54.264543,"median":-23.982021,"eighty":13.592632,"marketCap":88770184906},{"date":"2025-04-28","current":-143.077105,"twenty":-54.264543,"median":-23.982021,"eighty":13.592632,"marketCap":78268555347}],"updateTime":1745923377762}}}